NCT00444717View on ClinicalTrials.gov

Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Metabolic SyndromeOxidative StressInflammation
Interventions
DRUG

pitavastatin

Pitavastatin (2mg/day) was administered for 12 weeks

Trial Locations (1)

464-8651

Tatsuaki Matsubara, Nagoya

All Listed Sponsors
lead

Aichi Gakuin University

OTHER

NCT00444717 - Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter